Vitestro

𝗩𝗶𝘁𝗲𝘀𝘁𝗿𝗼 𝗙𝗲𝗮𝘁𝘂𝗿𝗲𝗱 𝗶𝗻 𝗧𝗵𝗲 𝗗𝗮𝗿𝗸 𝗥𝗲𝗽𝗼𝗿𝘁! Thank you to Robert Michel and The Dark Intelligence Group for the in-depth cover story on Vitestro and the Aletta™ Autonomous Robotic Phlebotomy Device™ (ARPD™). The article includes valuable insights from our co-founder, Brian Joseph, and Bob Gerberich, Chief Commercial Officer for North America. Read the full article here: https://lnkd.in/efct9AWq Aletta™ ARPD™ is not currently FDA approved and is not available for sale or use in the U.S. #Aletta #Vitestro #AutonomousPhlebotomy #ARPD

Curious to learn more about autonomous phlebotomy Aletta ™ and ask us all your questions? 𝗧𝗵𝗶𝘀 𝗔𝗽𝗿𝗶𝗹, you can meet us at events across three countries: 🔹𝗡𝗩𝗞𝗖 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 — 2-4 April — The Netherlands' leading event for clinical chemistry and laboratory medicine. Find us at booth #35 next week! https://lnkd.in/egVQ_hkC 🔹𝗜𝗻𝘀𝗽𝗶𝗿𝗲 𝗛𝗲𝗮𝗹𝘁𝗵 & 𝗖𝗮𝗿𝗲 — 23 –24 April — Bringing together healthcare professionals in Belgium to explore innovations that improve patient care. We're excited to bring Aletta™ to Belgium for the second time this year! Registration is still open, contact us to receive your personal invitation! https://lnkd.in/eTSvR8kd 🔹𝗘𝘅𝗲𝗰𝘂𝘁𝗶𝘃𝗲 𝗪𝗮𝗿 𝗖𝗼𝗹𝗹𝗲𝗴𝗲 (𝗘𝗪𝗖) — 29-30 April — The premier lab leadership conference in New Orleans, USA. Our clinical experts are eager to continue exploring the needs of US laboratories and their thoughts about Aletta™ ARPD™ and autonomous phlebotomy. https://lnkd.in/emGSXH-x Wherever you meet us, we look forward to meaningful conversations! #Vitestro #Aletta #ARPD #Phlebotomy

𝗡𝗼𝗿𝘁𝗵𝘄𝗲𝘀𝘁𝗲𝗿𝗻 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗮𝗻𝗱 𝗩𝗶𝘁𝗲𝘀𝘁𝗿𝗼 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗲 𝘁𝗼 𝗔𝗱𝘃𝗮𝗻𝗰𝗲 𝗔𝘂𝘁𝗼𝗻𝗼𝗺𝗼𝘂𝘀 𝗥𝗼𝗯𝗼𝘁𝗶𝗰 𝗣𝗵𝗹𝗲𝗯𝗼𝘁𝗼𝗺𝘆 We are proud to 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗲 𝘄𝗶𝘁𝗵 𝗡𝗼𝗿𝘁𝗵𝘄𝗲𝘀𝘁𝗲𝗿𝗻 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝘁𝗼 𝗮𝗱𝘃𝗮𝗻𝗰𝗲 𝗮𝘂𝘁𝗼𝗻𝗼𝗺𝗼𝘂𝘀 𝗿𝗼𝗯𝗼𝘁𝗶𝗰 𝗽𝗵𝗹𝗲𝗯𝗼𝘁𝗼𝗺𝘆. This multi-year collaboration marks an important step in bringing 𝗔𝗹𝗲𝘁𝘁𝗮™, 𝘁𝗵𝗲 𝘄𝗼𝗿𝗹𝗱’𝘀 𝗳𝗶𝗿𝘀𝘁 𝗔𝘂𝘁𝗼𝗻𝗼𝗺𝗼𝘂𝘀 𝗥𝗼𝗯𝗼𝘁𝗶𝗰 𝗣𝗵𝗹𝗲𝗯𝗼𝘁𝗼𝗺𝘆 𝗗𝗲𝘃𝗶𝗰𝗲™ (𝗔𝗥𝗣𝗗™), to healthcare settings in the U.S. As part of this collaboration, Northwestern Medicine will participate in a multicenter clinical trial to validate the performance and safety of Vitestro’s Aletta™ Autonomous Robotic Phlebotomy Device™ (ARPD™) in the U.S. The study aims to generate key clinical evidence supporting the adoption of automated phlebotomy as a scalable solution for U.S. hospitals and outpatient blood draw centers. Aletta™ is already CE-marked and commercially available in Europe, supporting hospitals and laboratories in optimizing diagnostic blood collection. We are excited to take this next step with Northwestern Medicine toward making autonomous blood collection a reality in the U.S. Read more in our press release: https://lnkd.in/eVc--vY3 #Aletta #Vitestro #AutonomousRoboticPhlebotomyDevice #ARPD #Phlebotomy #NorthwesternMedicine

𝗜𝗻𝘁𝗿𝗼𝗱𝘂𝗰𝗶𝗻𝗴 𝗔𝗹𝗲𝘁𝘁𝗮™ – 𝘁𝗵𝗲 𝘄𝗼𝗿𝗹𝗱’𝘀 𝗳𝗶𝗿𝘀𝘁 𝗔𝘂𝘁𝗼𝗻𝗼𝗺𝗼𝘂𝘀 𝗥𝗼𝗯𝗼𝘁𝗶𝗰 𝗣𝗵𝗹𝗲𝗯𝗼𝘁𝗼𝗺𝘆 𝗗𝗲𝘃𝗶𝗰𝗲™ For years, Vitestro has been developing cutting-edge robotic technology to transform blood collection. Today, we proudly reveal the name of our device: Aletta™, the first and only Autonomous Robotic Phlebotomy Device™ (ARPD™), an exclusive technology descriptor and new category of medical technology optimizing blood collection through automation. Aletta is named in honor of Dr. Aletta Jacobs, the first Dutch female physician, who contributed to healthcare with innovation and compassion. Just like her, Aletta stands for trust, empathy, and collaboration—helping healthcare professionals enhance efficiency while maintaining the human touch. With Aletta, we're shaping the future of phlebotomy. 🔗Read more in our press release: https://lnkd.in/eXHKKdVm #Aletta #Vitestro #AutonomousRoboticPhlebotomyDevice #ARPD #Phlebotomy #PhlebtomyAutomation

In the first episode of Greiner Bio-One Talks, clinical chemist Henk Ruven from St. Antonius Hospital shares his experience with our autonomous robotic phlebotomy device! The episode dives into: ✅ The role of digital solutions in pre-analytics (patient ID, tube labeling) ✅ AI and automation in pre-analytics ✅ Future innovations: sensors, non-invasive testing & preventive medicine 🔗 Listen here: https://lnkd.in/exPzHKhK #Automation #Preanalytics #Vitestro #Phlebotomy

This week, we attended the 𝐈𝐧𝟒𝐂𝐚𝐫𝐞 𝐍𝐞𝐰 𝐘𝐞𝐚𝐫'𝐬 𝐞𝐯𝐞𝐧𝐭 in Grimbergen, Belgium! In4Care is a dynamic member organization with over 350 members driving innovations in healthcare and well-being. This year’s theme, Grenzeloos Gezond (Boundlessly Healthy), set the stage for inspiring conversations about the future of healthcare. Our VP Marketing, Sales, and Customer Success in Europe, Maxine Moor, pitched our solution to the Belgian audience. We also had the opportunity to showcase our device during the networking reception, sparking insightful discussions. It was great to connect, answer questions, and gain valuable perspectives! A big thank you to In4Care for hosting this event! #Vitestro #In4care #Innovation

We are excited to announce the appointment of Bob Gerberich as Chief Commercial Officer for North America! With over 30 years of MedTech experience and a proven track record in launching innovative technologies, Bob will lead our U.S. pre-launch market development and the commercial launch of our autonomous robotic blood-draw device. Bob has an impressive history of driving exponential growth and shaping new markets. At Magnolia Medical Technologies, he established a new market for 'Initial Specimen Diversion Devices,' setting a new standard of care and achieving remarkable growth. At Invuity, Inc., he introduced a novel illumination and visualization technology, scaling revenue and leading the company to a successful IPO. As CCO for North America, Bob will work closely with Brian Joseph, Commercial Director and co-founder of Vitestro, and Andy McGibbon, Head of Strategy US, to redefine the future of blood drawing through our groundbreaking technology. Welcome to the team, Bob! Read the full press release here: https://lnkd.in/eRGFJcgP #NewHire #Vitestro #Phlebotomy #MedTech #BloodDraw

As we have kicked-off 2025, we want to reflect on an incredible 2024—a year filled with milestones and growth at Vitestro. Thank you for being part of our journey and supporting us every step of the way! Some of our highlights from 2024: ✅ 𝗖𝗘 𝗠𝗮𝗿𝗸𝗶𝗻𝗴 𝗔𝗰𝗵𝗶𝗲𝘃𝗲𝗱: In August , our autonomous blood drawing device received CE marking under the European Medical Device Regulation (MDR), paving the way for commercialization across the EU. ✅ $𝟮𝟮 𝗠𝗶𝗹𝗹𝗶𝗼𝗻 (€𝟮𝟬 𝗠𝗶𝗹𝗹𝗶𝗼𝗻) 𝗥𝗮𝗶𝘀𝗲𝗱: We’re excited to partner with Sonder Capital, NYBC Ventures, Invest-NL and European Innovation Council and SMEs Executive Agency (EISMEA) to accelerate our mission. ✅ 𝗦𝘁𝘂𝗱𝘆 𝗥𝗲𝘀𝘂𝗹𝘁𝘀 𝗦𝗵𝗮𝗿𝗲𝗱: At the IFCC WorldLab 2024 conference in Dubai in May, we presented the results of our A.D.O.P.T. Pivotal Trial Study Phase! ✅ 𝗧𝗲𝗮𝗺 𝗚𝗿𝗼𝘄𝘁𝗵: Our team expanded significantly, with new hires across engineering, customer success, marketing, sales, QA/RA, and more—including team members in the US and Denmark! ✅ 𝗢𝗿𝗱𝗲𝗿𝘀 𝗽𝗹𝗮𝗰𝗲𝗱 𝗮𝗰𝗿𝗼𝘀𝘀 𝗘𝘂𝗿𝗼𝗽𝗲: Multiple hospitals in the Netherlands and Denmark joined us in adopting our innovative technology. ✅ 𝗘𝘅𝗽𝗹𝗼𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗨𝗦 𝗺𝗮𝗿𝗸𝗲𝘁: We showcased the device to US laboratories at ADLM, where industry leaders were shared perspectives on how they could see the technology addressing significant pain points in the laboratory. We’re ready to make 2025 a success! Wishing you a successful and inspiring year ahead! #Innovation #Healthcare #NewBeginnings #Progress #Vitestro

𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐔𝐒🗽 Vitestro is taking another bold step forward in shaping the future of autonomous blood collection. From the vibrant heart of New York City, we’ll soon reveal an exciting milestone in our journey to transform healthcare. Stay tuned! #Vitestro #Phlebotomy #NewYork #healthcare #medtech #diagnostics

"𝐇𝐨𝐰 𝐝𝐨 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐟𝐞𝐞𝐥 𝐚𝐛𝐨𝐮𝐭 𝐡𝐚𝐯𝐢𝐧𝐠 𝐭𝐡𝐞𝐢𝐫 𝐛𝐥𝐨𝐨𝐝 𝐝𝐫𝐚𝐰𝐧 𝐛𝐲 𝐚 𝐝𝐞𝐯𝐢𝐜𝐞?" - It’s a question we hear often. Findings from our A.D.O.P.T. study (NCT05878483) show that: 🔹 98% of patients indicated acceptance of the new, automated method of blood drawing. 🔹 83% found the procedure to be less painful or equally comfortable compared to traditional manual blood draws. These results highlight the potential of our autonomous blood drawing device to improve patient comfort and streamline clinical care. As we move forward with implementation, we are excited to gather more valuable feedback from patients, to continue evolving our technology and enhancing patient experience. Find more study results here: https://lnkd.in/eJuYPa6F #PatientAdoption #Vitestro #MedTech #Phlebotomy